ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial.

Juan Pablo Alderuccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.